CFCYX
Price
$13.97
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
VBIAX
Price
$49.21
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
Ad is loading...

CFCYX vs VBIAX

Header iconCFCYX vs VBIAX Comparison
Open Charts CFCYX vs VBIAXBanner chart's image
Columbia Flexible Capital Income Inst3
Price$13.97
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Balanced Index Adm
Price$49.21
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CFCYX vs VBIAX Comparison Chart
Loading...
VS
CFCYX vs. VBIAX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFCYX is a Hold and VBIAX is a Buy.

FUNDAMENTALS
Fundamentals
VBIAX has more cash in the bank: 58.1B vs. CFCYX (1.24B). CFCYX pays higher dividends than VBIAX: CFCYX (5.56) vs VBIAX (1.98). CFCYX was incepted earlier than VBIAX: CFCYX (8 years) vs VBIAX (24 years). CFCYX is a more actively managed with annual turnover of: 44.00 vs. VBIAX (19.00). VBIAX has a lower initial minimum investment than CFCYX: VBIAX (3000) vs CFCYX (1000000). CFCYX annual gain was more profitable for investors over the last year : 20.63 vs. VBIAX (18.59). VBIAX (35.22) and CFCYX (34.25) have equivalent 5 years return.
CFCYXVBIAXCFCYX / VBIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD11.62011.471101%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B58.1B2%
Annual Yield % from dividends5.561.98281%
Returns for 1 year20.6318.59111%
Returns for 3 years2.221.61138%
Returns for 5 years34.2535.2297%
Returns for 10 yearsN/A85.59-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRML26.900.60
+2.28%
Tourmaline Bio
COEP0.20N/A
+1.06%
Coeptis Therapeutics Holdings
USFD61.760.32
+0.52%
US Foods Holding Corp
PTGX46.76N/A
N/A
Protagonist Therapeutics
VIGL3.87-0.01
-0.13%
Vigil Neuroscience